News


( Last Updated : July 30, 2021)

February 26, 2021
On February 25, CADTH issued our first provisional funding algorithm — a form of expert advice that supports provincial and territorial drug programs and cancer agencies in implementing our cancer drug reimbursement recommendations. CADTH can issue a provisional funding algorithm when a new…
February 19, 2021
Suzanne McGurn, President and CEO of CADTH, is the featured guest on a new episode of The NPC Podcast (S03, E03). She talks with host Peter Brenders — CEO of the New Brunswick Health Research Foundation — about taking the reins at CADTH, how the pandemic has affected CADTH’s work, and the evolving…
February 18, 2021
New horizon scan report offers patients, providers, and decision-makers insight on key health technologies that could transform the delivery of care OTTAWA, ON, February 17, 2021 — A new Watch List from CADTH identifies 10 emerging health technology trends that are poised to have a significant…
December 3, 2020
Feedback from more than 35 patient groups has helped CADTH update its Guidance for Providing Patient Input — a key resource for patient groups, patients, and caregivers who contribute to our reimbursement review process. The guide now addresses some of the key improvements suggested by patient…
November 26, 2020
Voretigene neparvovec (Luxturna) is the first gene therapy evaluated through the CADTH reimbursement review process CADTH recommends reimbursement with conditions, including a price reduction, and offers advice on implementing the recommendation On November 16, CADTH recommended that Canada’s…